Free Trial

Edesa Biotech (EDSA) SEC Filings & 10K Form

Edesa Biotech logo
$3.20
-0.10 (-3.03%)
(As of 11/1/2024 ET)

Recent Edesa Biotech SEC Filings

DateFilerForm TypeView
10/31/2024
7:30 AM
Edesa Biotech, Inc. (Filer)
Edesa Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2024
3:55 PM
Edesa Biotech, Inc. (Filer)
Edesa Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2024
4:05 PM
Edesa Biotech, Inc. (Filer)
Edesa Biotech (Filer)
Form 424B5
10/02/2024
8:30 PM
Edesa Biotech, Inc. (Issuer)
Edesa Biotech (Issuer)
Nijhawan Pardeep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
7:00 PM
Edesa Biotech, Inc. (Issuer)
Edesa Biotech (Issuer)
Nijhawan Pardeep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2024
3:45 PM
Edesa Biotech, Inc. (Filer)
Edesa Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2024
3:30 PM
Edesa Biotech, Inc. (Filer)
Edesa Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2024
8:01 PM
Edesa Biotech, Inc. (Issuer)
Edesa Biotech (Issuer)
Nijhawan Pardeep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
8:00 PM
Edesa Biotech, Inc. (Issuer)
Edesa Biotech (Issuer)
Nijhawan Pardeep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
7:31 AM
Edesa Biotech, Inc. (Filer)
Edesa Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2024
8:01 PM
Edesa Biotech, Inc. (Issuer)
Edesa Biotech (Issuer)
Nijhawan Pardeep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
3:10 PM
Edesa Biotech, Inc. (Subject)
Edesa Biotech (Subject)
SATTERFIELD THOMAS A JR (Filed by)
Form SC 13G
05/30/2024
4:04 PM
Edesa Biotech, Inc. (Filer)
Edesa Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2024
3:46 PM
Edesa Biotech, Inc. (Filer)
Edesa Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/01/2024
8:30 PM
Edesa Biotech, Inc. (Issuer)
Edesa Biotech (Issuer)
Nijhawan Pardeep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2024
3:34 PM
Edesa Biotech, Inc. (Filer)
Edesa Biotech (Filer)
Form ARS
04/05/2024
3:30 PM
Edesa Biotech, Inc. (Filer)
Edesa Biotech (Filer)
Form DEF 14A
04/05/2024
3:31 PM
Edesa Biotech, Inc. (Filer)
Edesa Biotech (Filer)
Form DEFA14A
04/02/2024
6:02 PM
Edesa Biotech, Inc. (Issuer)
Edesa Biotech (Issuer)
Nijhawan Pardeep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
6:00 PM
Edesa Biotech, Inc. (Issuer)
Edesa Biotech (Issuer)
Nijhawan Pardeep (Reporting)
Pardeep Nijhawan Medicine Professional Corp (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
5:20 PM
Edesa Biotech, Inc. (Issuer)
Edesa Biotech (Issuer)
Nijhawan Pardeep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
3:46 PM
Edesa Biotech, Inc. (Filer)
Edesa Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/09/2024
3:20 PM
Edesa Biotech, Inc. (Filer)
Edesa Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/02/2024
8:30 PM
Edesa Biotech, Inc. (Issuer)
Edesa Biotech (Issuer)
Nijhawan Pardeep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2024
3:29 PM
Edesa Biotech, Inc. (Subject)
Edesa Biotech (Subject)
Velan Capital Investment Management LP (Filed by)
Form SC 13G/A
01/12/2024
4:30 PM
Edesa Biotech, Inc. (Issuer)
Edesa Biotech (Issuer)
Nijhawan Pardeep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2023
3:44 PM
Edesa Biotech, Inc. (Filer)
Edesa Biotech (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:EDSA) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners